
DG · NYSE
Consensus is Hold across 32 analysts, with a mean price target of $139; supplied data do not provide low or high targets, so the target cluster and spread cannot be measured. The evidence also does not identify which analyst is most or least bullish. The only explicitly stated recent revision is Barclays’ reduction of its target to $148 from $151 while retaining an Overweight rating, indicating a downward individual revision rather than a clearly positive weekly trend. The substantive disagreement is between improving operating evidence—3.5% comparable-sales growth, margin expansion and higher guidance—and the broader Hold consensus, which signals caution about the durability of the recovery and limits to valuation upside.